Jason A. Femrite

Jason A. Femrite: Attorney with Procopio, Cory, Hargreaves & Savitch LLP AV stamp icon
Attorney Awards

Biography

Professional Summary

Jason A. Femrite represents both private and publicly held companies, fund and investment firms in a wide range of transactions from structure and formation to capitalization and finance, and sale and acquisition. Jason’s practice focuses on mergers and acquisitions, private equity, corporate and venture finance, securities and general corporate matters. His experience in these areas includes the representation of both buyers and sellers in mergers, management buyouts, stock and assets sales and private placements. In such capacity, Jason has represented companies in a wide range of industries, including life sciences, medical devices, software and online services, sports and outdoor products, clean tech and engineered products.

Recognitions

•Martindale-Hubbell AV Preeminent Rating
• Southern California’s Top Rated Lawyers, Legal Leaders, 2012-2016
San Diego Business Journal Best of the Bar, 2015
•“Top Lawyers,” San Diego Magazine, 2013-2018

News Coverage

•“M&A: One Stop Systems Buys German Tech Supplier with Help from Procopio, San Diego Daily Transcript, November 20, 2018.
•“Health Care Staffing Businesses Combine with Procopio Counsel,” November 13, 2018.
•“Exact Sciences Buy Biomatrica with Help from Procopio, Reed Smith,” San Diego Daily Transcript, October 30, 2018.
•“Linden Capital Invests in Solara Medical Supplies,” San Diego Daily Transcript, June 12, 2018.
•“Procopio Assists Nutpods in Securing Investment,” The Daily Transcript, December 19, 2017.
•“Simulations Plus taps Procopio in its purchase of simulation software provider for up to 10M,” Los Angeles Daily Journal, May 9, 2017.
• “Confluence Outdoor Acquires Boardworks, ” Business Wire, January 5, 2015.
•Dorbian, Iris. “BRS Backs Rock-Climbing Shoe Brand Evolv, ” The PE Hub Network, August 7, 2014.
•Fracassa, Dominic. “Procopio represents Italian drugmaker in sale to Salix,” Daily Journal, July 11, 2014.
•Evans, Jeremy. “Time Out: How we Represent and Play in the Big Leagues,” San Diego Lawyer, July 1, 2013.
• Jason Femrite Joins the SDSI Advisory Board, TransWorld Business, May 2, 2012.
• Procopio Partner Named to SD Sport Innovators Advisory Board, SD Metro, May 1, 2012.
• Action Sports and Apparel Lawyer Jason Femrite Joins SDSI Advisory Board, Malakye, April 30, 2012.

(Also at Irvine Office)

Areas of Practice (8)

  • Corporate and Securities
  • Emerging Growth and Venture Capital
  • Life Sciences
  • Medical Technology
  • Mergers & Acquisitions and Strategic Joint Ventures
  • Software
  • Sports and Active Lifestyle
  • Technology Transactions

Education & Credentials

Contact Information:
858.720.6334  Phone
858.523.4309  Fax
www.procopio.com
University Attended:
University of California, San Diego, BA, Political Science, 1996
Law School Attended:
University of San Diego School of Law, JD, cum laude, Order of the Coif, 1999
Year of First Admission:
1999
Admission:
1999, California
Memberships:

Community

•Association of Corporate Growth - Board of Directors
•San Diego County Bar Association
•San Diego Sport Innovators - Board of Directors
•San Diego Venture Group
•Surf Industry Manufacturers Association
•The State Bar of California
•UCSD Alumni Association

Reported Cases:
Representative Matters: Mergers and Acquisitions Represented medical supply company in its 160M sale to a leading healthcare private equity firm.; Represented behavioral health company in its 33M sale to a leading private equity construction firm.; Represented high end hunting gear company in its 50,000,000 sale of minority interest to leading private consumer growth equity firm.; Represented leasing platform housing company in its 250M sale to a leading Nasdaq provider of real estate software and data analytics company.; Represented golf simulation company in its 30M sale to a private equity firm and golf manufacturing company.; Represented Nasdaq software simulation company in its acquisition of a clinical trial data analysis company and a drug -induced liver analysis company valued at over 15M.; Represented Irish pharmaceutical company in 2.5B merger with a NASDAQ pharmaceutical company.; Represented management in their 165M buyout of the US operations of a large London Stock Exchange homebuilder, which included a separately negotiated 60M private financing component.; Represented medical device manufacturer in its 30M sale to German acquirer.; Represented transportation company in its 27M acquisition by a private equity fund.; Represented NYSE company in acquisition of 50 cash advance companies in Southern California.; Represented Italian biotech company in significant licensing/stock deal with NASDAQ biopharma company.; Represented large privately held international life-sciences company in connection with the 95M sale of its, and its subsidiaries, outstanding capital stock to a global provider of biological products and enabling technologies listed on the NASDAQ national stock market.; Represented a large state pension fund in connection with the disposition of its approximately 70M investment in two international real estate funds.; Represented a subsidiary of a large publicly-traded homebuilder in connection with the approximately 48M acquisition of all of the outstanding equity of a local developer.; Represented a leading wholesale distributor in connection with strategic acquisitions totaling more than 45M.; Represented large privately held foreign corporation in connection with its 30M acquisition of US-based software company.; Represented Internet-based information technology company in connection with its 30M acquisition by a large strategic partner.; Represented manufacturer of telecommunications equipment in connection with the approximately 25M acquisition of all of its outstanding equity to the US subsidiary of a large international conglomerate.; Represented manufacturer in aerospace industry in connection with the sale of all of its outstanding equity for approximately 20M to a private equity fund. Financings Represented high end hunting gear company in its 50,000,000 sale of minority interest to leading private consumer growth equity firm.; Represented Irish biotechnology company in 87M secondary public offering of shares in a NASDAQ biopharmaceutical company.; Represented one of a group of investors in connection with the 500M financing of a production company.; Represented a pharmaceutical company listed on NASDAQ in connection with 45M of PIPE financings.; Represented a private company providing tools to foster safer driving and to aid in crash reconstruction in connection with an offering of Series D Preferred Stock to investors for approximately 41M.; Represented one of a group of investors in connection with the 40.5M financing of an AMEX listed pharmaceutical company.; Represented underwriter in connection with a 15M firmly underwritten public offering.; Represented provider of interactive digital broadband services in connection with 15M financing by several institutional investors led by NYSE listed company.
ISLN:
914961893

Peer Reviews

San Diego, California

Contact Jason A. Femrite

Required Fields

Required Fields


By clicking on the "Submit" button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Martindale and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.